Onconetix, Inc. Payments for Repurchase of Private Placement
Onconetix, Inc. (ONCO) reported Payments for Repurchase of Private Placement of $845.05 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPrivatePlacement · last filed 2024-04-11
- Onconetix, Inc. payments for repurchase of private placement for fiscal 2022 was $845.05K.
| Period end | Payments for Repurchase of Private Placement 6 month | Payments for Repurchase of Private Placement 12 month |
|---|---|---|
| 2022-12-31 | $845.05K 10-K · filed 2024-04-11 | |
| 2022-06-30 | $349.63K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |